Article
Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study.
Gynecologic oncology - 1 Oct 2021
Arend Rebecca C, Goel Nidhi, Roane Brandon M, Foxall McKenzie E, Dholakia Jhalak, Londoño Angelina I, Wall Jaclyn A, Leath Charles A, Huh Warner K
Abstract excerpt
BACKGROUND: Both incidence and mortality of uterine cancer are on the rise and mortality is higher for African American women. The aim of our study was to evaluate how Next Generation Sequencing (NGS) may facilitate identification of and intervention for treatment disparities when integrated into clinical workflows. RESULTS: Our cohort included 159 uterine cancer patients with recurrent/progressive and newly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.